Laniroif Interactions
There are 896 drugs known to interact with Laniroif (aspirin/butalbital/caffeine), along with 29 disease interactions, and 6 alcohol/food interactions. Of the total drug interactions, 98 are major, 743 are moderate, and 55 are minor.
- View all 896 medications that may interact with Laniroif
- View Laniroif alcohol/food interactions (6)
- View Laniroif disease interactions (29)
Most frequently checked interactions
View interaction reports for Laniroif (aspirin / butalbital / caffeine) and the medicines listed below.
Laniroif alcohol/food interactions
There are 6 alcohol/food interactions with Laniroif (aspirin / butalbital / caffeine).
Laniroif disease interactions
There are 29 disease interactions with Laniroif (aspirin / butalbital / caffeine) which include:
- coagulation
- acute alcohol intoxication
- drug dependence
- liver disease
- porphyria
- rash
- respiratory depression
- cardiac disease
- hypertension
- psychiatric disorders
- PUD
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- adrenal insufficiency
- depression
- hematologic toxicity
- osteomalacia
- paradoxical reactions
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Report options
More about Laniroif (aspirin / butalbital / caffeine)
- Laniroif consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: analgesic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.